Mitochondrial quality control in lung diseases: current research and future directions

Mitochondrial quality control in lung diseases: current research and future directions

Lung diseases are a major global health problem, affecting millions of people worldwide. Recent research has highlighted the critical role that mitochondrial quality control plays in respiratory-related diseases, including chronic obstructive pulmonary disease (COPD), lung cancer, and idiopathic pul...

Full description

Bibliographic Details
Main Authors:	Jiliu Liu, Junyi Wang, Anying Xiong, Lei Zhang, Yi Zhang, Yao Liu, Ying Xiong, Guoping Li, Xiang He
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-07-01
Series:	Frontiers in Physiology
Subjects:	mitochondrial quality control chronic obstructive pulmonary disease lung cancer idiopathic pulmonary fibrosis therapeutic approaches
Online Access:	https://www.frontiersin.org/articles/10.3389/fphys.2023.1236651/full

Similar Items

Research Progress on Pathogenic Mechanism and Potential Therapeutic Drugs of  Idiopathic Pulmonary Fibrosis Complicated with Non-small Cell Lung Cancer
by: Ting XIAO, et al.
Published: (2022-10-01)

Factors associated with listing for lung transplantation in IPF patients: An analysis of the pulmonary fibrosis foundation registry
by: Christopher S. King, et al.
Published: (2023-08-01)

Diagnostic and Therapeutic Challenges for Patients with Pulmonary Hypertension due to Lung Diseases
by: Laurent Godinas, et al.
Published: (2022-04-01)

Recent Advances in Molecular Basis of Lung Aging and Its Associated Diseases
by: Min-Jong Kang, M.D., M.P.H., Ph.D.
Published: (2020-04-01)

Pulmonary Fibrosis and Progressive Pulmonary Fibrosis in a Prospective Registry of Interstitial Lung Diseases in Eastern Siberia
by: Maria S. Nashatyreva, et al.
Published: (2023-01-01)

Identification of SULF1 as a Shared Gene in Idiopathic Pulmonary Fibrosis and Lung Adenocarcinoma
by: Junyi WANG, et al.
Published: (2023-09-01)

Idiopathic pulmonary fibrosis: current diagnosis and treatment
by: Alexandre Franco Amaral, et al.
Published: (2023-08-01)

The application of metabolomics toward idiopathic pulmonary fibrosis and potential metabolomic value of diverse samples in interstitial lung diseases
by: Mingtao Liu, et al.
Published: (2023-09-01)

Treprostinil Reconstitutes Mitochondrial Organisation and Structure in Idiopathic Pulmonary Fibrosis Cells
by: Lei Fang, et al.
Published: (2023-07-01)

Incidence and Clinical Characteristics of Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis
by: Wei Yan, et al.
Published: (2015-01-01)

MMP14high macrophages orchestrate progressive pulmonary fibrosis in SR-Ag-induced hypersensitivity pneumonitis
by: Dan Peng, et al.
Published: (2024-02-01)

Reciprocal interactions between alveolar progenitor dysfunction and aging promote lung fibrosis
by: Jiurong Liang, et al.
Published: (2023-06-01)

Fine particulate matter 2.5 induces susceptibility to Pseudomonas aeruginosa infection via expansion of PD-L1high neutrophils in mice
by: Li Luo, et al.
Published: (2024-02-01)

Editorial: Perspectives in pharmacological therapy targeting cellular metabolic pathways in respiratory diseases
by: Na Wang, et al.
Published: (2023-11-01)

Clinicopathological Outlines of Post-COVID-19 Pulmonary Fibrosis Compared with Idiopathic Pulmonary Fibrosis
by: Roxana-Elena Cîrjaliu, et al.
Published: (2023-06-01)

Mitochondrial Quality Control in COPD and IPF
by: Hiromichi Hara, et al.
Published: (2018-07-01)

Research Progress on the Pathogenesis of Lung Cancer Associated with  Idiopathic Pulmonary Fibrosis
by: Qiangwei LU, et al.
Published: (2022-11-01)

Deep learning diagnostic and severity-stratification for interstitial lung diseases and chronic obstructive pulmonary disease in digital lung auscultations and ultrasonography: clinical protocol for an observational case–control study
by: Johan N. Siebert, et al.
Published: (2023-06-01)

An observational cohort study of interstitial lung abnormalities (ILAs) in a large Japanese health screening population (Kumamoto ILA study in Japan: KILA-J)
by: Kazuya Ichikado, et al.
Published: (2023-06-01)

Potential targeted therapy based on deep insight into the relationship between the pulmonary microbiota and immune regulation in lung fibrosis
by: Tao Zhang, et al.
Published: (2023-01-01)

Systematic Review and Metanalysis of Oncomarkers in IPF Patients and Serial Changes of Oncomarkers in a Prospective Italian Real-Life Case Series
by: Miriana d’Alessandro, et al.
Published: (2021-01-01)

Disparities in pulmonary fibrosis care in the United States: an analysis from the Nationwide Inpatient Sample
by: Adam W. Gaffney, et al.
Published: (2018-08-01)

Mitochondrial dysfunction in pulmonary arterial hypertension
by: Weiwei Zhang, et al.
Published: (2022-12-01)

Multiform-based Baduanjin exercise prevention and treatment for idiopathic pulmonary fibrosis: study protocol for a randomized controlled trial
by: Zenan Wu, et al.
Published: (2023-05-01)

Transcriptome and pan-cancer system analysis identify PM2.5-induced stanniocalcin 2 as a potential prognostic and immunological biomarker for cancers
by: Dong Zhu, et al.
Published: (2023-01-01)

Bibliometric analysis of the pirfenidone and nintedanib in interstitial lung diseases
by: Jia Liu, et al.
Published: (2024-04-01)

Idiopathic pulmonary fibrosis - a disorder of alveolar wound repair?
by: Swiss Medical Weekly
Published: (2003-07-01)

Induction and Modulation of EVs by Cigarette Smoke and Their Relevance in Lung Disease: Recent Advances
by: Mengli Zhong, et al.
Published: (2023-09-01)

Fibrocytes are increased in lung and peripheral blood of patients with idiopathic pulmonary fibrosis
by: P. Heukels, et al.
Published: (2018-05-01)

Inhibition of ROCK ameliorates pulmonary fibrosis by suppressing M2 macrophage polarisation through phosphorylation of STAT3
by: Qingfang Li, et al.
Published: (2022-10-01)

Small airway dysfunction in idiopathic pulmonary fibrosis
by: Chengsheng Yin, et al.
Published: (2022-10-01)

Pulmonary hypertension in patients with interstitial lung disease: a tool for early detection
by: Raj Parikh, et al.
Published: (2022-10-01)

Quantification of Cancer-Developing Idiopathic Pulmonary Fibrosis Using Whole-Lung Texture Analysis of HRCT Images
by: Chia-Hao Liang, et al.
Published: (2021-11-01)

Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges
by: Spagnolo Paolo, et al.
Published: (2012-11-01)

Validation of the recording of idiopathic pulmonary fibrosis in routinely collected electronic healthcare records in England
by: Ann Morgan, et al.
Published: (2023-07-01)

Pulmonary nocardiosis following COVID-19 in a patient with idiopathic pulmonary fibrosis and lung transplantation: a case report
by: Liming Cao, et al.
Published: (2023-09-01)

Clinical course and management of idiopathic pulmonary fibrosis
by: Caitlin Quinn, et al.
Published: (2019-12-01)

Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative—Group 3 Pulmonary Hypertension
by: Oksana A. Shlobin, et al.
Published: (2024-01-01)

Pulmonary hypertension associated with chronic lung diseases
by: Manuela Funke, et al.
Published: (2016-09-01)

Impact of ILD-Specific Therapies on Perioperative Course in Patients with Progressive Interstitial Lung Disease Undergoing Lung Transplantation
by: Dieter Munker, et al.
Published: (2023-07-01)